NewsBytes
    Hindi Tamil Telugu
    More
    In the news
    Narendra Modi
    Amit Shah
    Box Office Collection
    Bharatiya Janata Party (BJP)
    OTT releases
    Hindi Tamil Telugu
    NewsBytes
    User Placeholder

    Hi,

    Logout


    India Business World Politics Sports Technology Entertainment Auto Lifestyle Inspirational Career Bengaluru Delhi Mumbai Visual Stories Find Cricket Statistics Phones Reviews Fitness Bands Reviews Speakers Reviews

    Download Android App

    Follow us on
    • Facebook
    • Twitter
    • Linkedin
     
    Home / News / India News / Coronavirus: Trials for 4 AYUSH formulations to start within week
    Coronavirus: Trials for 4 AYUSH formulations to start within week
    1/7
    India 2 min read

    Coronavirus: Trials for 4 AYUSH formulations to start within week

    By Siddhant Pandey
    May 15, 2020
    01:44 am
    Coronavirus: Trials for 4 AYUSH formulations to start within week

    Union Minister Shripad Y Naik on Thursday said that the AYUSH Ministry and the Council of Scientific and Industrial Research (CSIR) are working on four AYUSH formulations against COVID-19. Naik is the Union Minister of State for AYUSH (Ayurveda, Yoga and Naturopathy, Unani, Siddha, and Homoeopathy). The four formulations are expected to start trials within a week. Here are more details.

    2/7

    AYUSH formulations will be tried as add-on therapy for patients

    Naik tweeted, "The AYUSH Ministry and the CSIR are working together on validating four AYUSH formulations against COVID-19 pandemic and the trials will start within one week." "These formulations will be tried as an add-on therapy and standard care for COVID-19 patients," Naik added, "I am sure and quite hopeful that our traditional medicinal system will show the way to overcome this pandemic."

    3/7

    You can view Naik's tweet here

    I am sure and quite hopefull that, our traditional medicinal system will show the way to overcome this Pandemics.

    — Shripad Y. Naik (@shripadynaik) May 14, 2020
    4/7

    What are the four formulations?

    AYUSH Secretary Vaidya Rajesh Kotecha told ANI, "These four candidates are Ashwagandha, Yashtimadhu (Mulethi), Guduchi + Pippali (Giloy) and AYUSH-64, which was invented for the treatment of malaria and its repurposing is going on." He said they are conducting two kinds of stimulus studies as profile access on the high-risk population for Ashwagandha. A competitive study of hydroxychloroquine and Ashwagandha is also planned.

    5/7

    Centers and investigators finalized for trial

    Kotecha said that he met CSIR Director-General, Dr. Shekhar Mande, on Wednesday and they finalized centers and investigators for the trial. Kotecha said they procured the requisite approvals to start the trial along with standard drugs. "We cannot just buy it from the market and we need to have a standard size requirement of the drugs," he told ANI.

    6/7

    Results of trial to come out in three months

    Mande and Kotecha said the trial results will be announced within three months. Kotecha said that they took advice from the Indian Council of Medical Research for the study so that it "becomes so robust that it should be publishable into a very high-impact journal."

    7/7

    'This type of study has never happened in India'

    Kotecha told ANI, "This is once in a lifetime opportunity. This type of study has never happened in our country." He added, "We have formed the task force and have prepared guidelines for the clinical trial. Some of the best scientists of the country from the medical field, from CSIR and others, have also reviewed this."

    Facebook
    Whatsapp
    Twitter
    Linkedin
    Related News
    Shripad Naik
    Council of Scientific and Industrial Research
    Ministry of AYUSH
    Coronavirus
    COVID-19

    Shripad Naik

    Goa mining: Several ministers, politicians to support GMPF's Delhi protest Supreme Court Of India
    BJP does not respect democracy: Goa Congress spokesperson Karnataka
    Three soldiers martyred along LoC due to Pakistan shelling India
    Union Minister Shripad Naik injured, wife, aide killed in accident Goa

    Council of Scientific and Industrial Research

    #CareerBytes: All you need to know about GATE and UGC-NET India
    #CareerBytes: Five reasons why you should appear for GATE exam India
    What career options do you have after cracking GATE? Exams
    #CareerBytes: Five reasons why you should appear for GATE exam India

    Ministry of AYUSH

    Coronavirus: Netizens slam AYUSH Ministry for recommending Ayurveda, Unani Press Information Bureau
    Cows and BJP: 5 times its ministers made silly remarks Ministry of Health and Family Welfare
    Health Minister says ex-PM Morarji Desai consumed cow urine Bhopal
    Is chicken veg or non-veg? Shiv Sena MP demands clarification Narendra Modi

    Coronavirus

    Don't return, get Rs. 10,000: Nagaland's idea of staying coronavirus-free Nagaland
    Trump calls Fauci's warning against reopening US schools 'not acceptable' Donald Trump
    In lockdown 4.0, public transport will be allowed with limits India
    Man woke from coma to learn coronavirus had killed wife United States of America

    COVID-19

    Coronavirus: India's death toll reaches 2,542; Maharashtra tally crosses 25,000 Odisha
    Chinese hackers tried stealing US COVID-19 vaccine research: Details here Federal Bureau of Investigation
    Inventor of N95 masks is making them reusable: Here's how Technology
    MP: Crowd gathers to welcome monk; social distancing norms violated Madhya Pradesh
    Next News Article

    Love India News?

    Subscribe to stay updated.

    India Thumbnail
    Indian Premier League (IPL) Celebrity Hollywood Bollywood UEFA Champions League Tennis Football Smartphones Cryptocurrency Upcoming Movies Premier League Cricket News Latest automobiles Latest Cars Upcoming Cars Latest Bikes Upcoming Tablets
    About Us Privacy Policy Terms & Conditions Contact Us Ethical Conduct Grievance Redressal News News Archive Topics Archive Download DevBytes Find Cricket Statistics
    Follow us on
    Facebook Twitter Linkedin
    All rights reserved © NewsBytes 2023